Imagion Biosystems Ltd. has released a press release.
IBX Secures Central Ethics Approval - Key Phase 2 Milestone
Earlier from Imagion Biosystems
- Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities
- MagSense Nanoparticle Manufacturing Update
- IBX Phase 2 Clinical Trial Update
- Appendix 4C and Quarterly Activities Report - June 2026